Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
<p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. The pathogenesis has not been fully deciphered. PCOS is associated with insulin resistance (IR), menstrual irregularities, cardiovascular disease, obesity, hirsutism, infertili...
Gardado en:
Main Authors: | Rim Hanna (Author), Tarek Wehbe (Author), Elizabeth Abou Jaoude (Author) |
---|---|
Formato: | Libro |
Publicado: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2017-11-01.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
por: Iñaki Lete, et al.
Publicado: (2024) -
Comparing Myo-Inositol and Folic Acid with and without D-Chiro-Inositol for The Management of Polycystic Ovary Syndrome
por: Reja Akram, et al.
Publicado: (2024) -
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
por: Tatiana A. Oboskalova, et al.
Publicado: (2020) -
Efficiency of the D-chiro-inositol for the polycystic ovary syndrome
por: Т. Л. Архипкина, et al.
Publicado: (2019) -
A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
por: Sujana Thalamati
Publicado: (2020)